DCF — PARKLAND MEDICAL CENTER
Enterprise Value: $101.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$101.2M
Enterprise Value
$25.7M
PV of Cash Flows
$75.4M
PV of Terminal Value
$121.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $163.5M | $13.9M | 9.0% | $4.5M | $4.1M |
| Year 2 | $168.4M | $16.0M | 10.0% | $5.9M | $4.9M |
| Year 3 | $173.4M | $18.2M | 11.0% | $7.4M | $5.6M |
| Year 4 | $178.6M | $19.7M | 11.0% | $8.3M | $5.7M |
| Year 5 | $184.0M | $20.7M | 11.0% | $8.9M | $5.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $101.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$158.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000075601522
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5